683 Capital Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

683 Capital Management’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-90,000	Closed	-$1.78M	–	162
2018 Q1	$1.78M	Hold	90,000	–	–	0.16%	84
2017 Q4	$1.75M	Hold	90,000	–	–	0.15%	95
2017 Q3	$1.75M	Buy	+90,000	New	+$1.75M	0.18%	81

Other funds holding DMTK

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

MSU

Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

WRBC

W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

683 Capital Management's DMTK Position: Q2 2018 in Review

683 Capital Management sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2018, closing a stake of 90,000 shares — an estimated $1.78M sold.

683 Capital Management first reported a position in DMTK in Q3 2017 and held it in 3 quarters. The position peaked at $1.78M in Q1 2018. 22 funds tracked by Wall St. Rank hold DMTK as of Q2 2018.

683 Capital Management reported no remaining DermTech, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
683 Capital Management sold 90,000 DermTech, Inc. Common Stock shares in Q2 2018, an estimated $1.78M.
683 Capital Management first reported a position in DermTech, Inc. Common Stock in Q3 2017 and held it in 3 quarters.
683 Capital Management's DermTech, Inc. Common Stock position peaked at $1.78M in Q1 2018.
22 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2018.

Based on 683 Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.